Clinical and Functional Results of the Use of Suspension of Autologous Mononuclear Leucocytes in the Surgical Treatment of Bullous Keratopathy

Author:

Denisko M. S.1ORCID,Krivosheina O. I.1ORCID,Ivanova E. V.1ORCID

Affiliation:

1. Siberian State Medical University; LTD Grand Retina

Abstract

The purpose: to explore the clinical effectiveness of a new cell-based surgical method for the treatment of bullous keratopathy that includes intrastromal injection of autologous mononuclear leukocytes into the posterior third of the cornea stroma.Material and methods. The study included 58 patients with diagnosis of bullous kerathopathy. They were divided into 2 groups — the main group received surgical treatment by the presented method; and the comparison group received a course of conservative therapy.Results. In 10 days the patients in the main group had a normal structure of the cornea epithelium, slight edema of the stroma, thin folds of the Descemet’s membrane and moderate edema of the endothelium. Similar results in the comparison group were achieved in 1 month, and it was the best condition of the cornea. Later corneal edema increased. In 3 months the patients of the main group had a normal structure of corneal epithelium, single thin folds of the Descemet’s membrane, slight edema of the posterior third of the stroma only in the optical zone, and slight edema of the endothelium. The achieved results were preserved for 12 months. The best correct visual acuity (BCVA) in the main group was achieved by the 6th month. It increased 10 times from the initial level, and the corneal thickness decreased by 27 % from the initial level by the 9th month. In the comparison group, the BCVA was achieved by the 1st month. It increased 2.7 times from the initial level; the maximum decrease in the index of pachymetry by 6.7 % was achieved by the 3rd month from the initial level, and then these parameters increased.Conclusion. The using of a surgical method for the treatment of bullous keratopathy, including intrastromal injection of suspension of autologous mononuclear leukocytes, contributes to the relief of corneal syndrome, increases the transparency of the cornea and restores its normal thickness. These changes are accompanied by increase of BCVA in the postoperative period compared to the course of conservative therapy. 

Publisher

PE Polunina Elizareta Gennadievna

Subject

Ophthalmology

Reference11 articles.

1. Xian B., Zhang Y., Peng Y., Huang J., Li W., Wang W., Zhang M., Li K., Zhang H., Zhao M., Liu X., Huang B. Adult Human Peripheral Blood Mononuclear Cells Are Capable of Producing Neurocyte or Photoreceptor-Like Cells That Survive in Mouse Eyes After Preinduction With Neonatal Retina. Stem cells translational medicine. 2016;5(11):1515–1524. DOI: 10.5966/sctm.2015-0395

2. Hu J., Wang Y., Jiao J., Liu Z., Zhao C., Zhou Z., Zhang Z., Forde K., Wang L., Wang J., Baylink D.J., Zhang X.B., Gao S., Yang B., Chen Y.E., Ma P.X. Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration. Biomaterials. 2015;73:51–59. DOI: 10.1016/j.biomaterials.2015.09.008

3. Avetisov S.Eh., Kasparova E.A, Kasparov A.A., Subbot A.M., Antokhin A.I., Pavlyuk A.S., Fadeeva L.L., Feofanov S.A. Personalized cell-based therapy in ophthalmology. III. Clinical efficacy in the treatment of corneal endothelial diseases. Geny i kletki = Genes and Cells. 2018;XII(4):69–74 (In Russ.). DOI: 10.23868/201812049

4. Astakhov S.Yu., Riks I.A., Papanyan S.S., Kasparov A.A., Kasparova Evg.A., Pavlyuk A.S., Fedotova K. Experience in personalized cell therapy clinical implementation for treatment of patients with primary endothelial dystrophy after phacoemulsification. Oftal’mologicheskie vedomosti = Ophthalmology Journal. 2017;10(4):6–12 (In Russ.) DOI: 10.17816/OV1046-12

5. Bikbov M.M., Shevchuk N.E., Mal’khanov V.B. Cytokines in ophthalmology. Ufa: Ufimskiy poligrafkombinat; 2008 (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3